🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this randomized, double-blind, placebo-controlled study is t...
Status
Completed
Location
Southern Cancer Center
Start Date
2013-06
Trial ID
NCT01873703
Treatments Being Tested
The purpose of Part 1 (Dose Escalation) of the study is to assess the effec...
Status
Recruiting
Location
Concord Hospital
Start Date
2025-03-21
Trial ID
NCT06651229
Treatments Being Tested
This phase II trial studies how well sirolimus and azacitidine works in tre...
Status
Completed
Location
Jefferson Health NJ Division (Kennedy Hospital)
Start Date
2013-07-08
Trial ID
NCT01869114
Treatments Being Tested
The purpose of this open label study is to determine whether combining prac...
Status
Completed
Location
Southern Cancer Center
Start Date
2013-12
Trial ID
NCT01993641
Treatments Being Tested
This is a multicenter, nonrandomized, open-label phase 2 study (with a safe...
Status
Completed
Location
Johns Hopkins Oncology Center
Start Date
2016-07
Trial ID
NCT02845297
Treatments Being Tested
The purpose of this study is to assess the activity of 5-azacitidine in pat...
Status
Completed
Location
Smilow Cancer Center at Yale New Haven Hospital
Start Date
2015-02-19
Trial ID
NCT02178072
Treatments Being Tested
This phase II trial studies how well azacitidine and venetoclax with or wit...
Status
Active Not Recruiting
Location
Smilow Cancer Hospital Care Center at Greenwich
Start Date
2021-02-16
Trial ID
NCT04284787
The purpose of this study is to determine the safety and effectiveness of p...
Status
Completed
Location
City of Hope Comprehensive Cancer Ctr
Start Date
2013-12-24
Trial ID
NCT01912274
Treatments Being Tested
Phase II trial combining azacitidine with valproic acid as maintenance ther...
Status
Unknown
Location
Loyola University Cardinal Bernardin Cancer Center
Start Date
2012-01
Trial ID
NCT02124174
Treatments Being Tested
The FMS tyrosine kinase 3 (FLT3) gene mutation occurs in 30% of newly diagn...
Status
Recruiting
Location
Blood Diseases Hospital
Start Date
2024-10-08
Trial ID
NCT06561880
Treatments Being Tested